Transforming genetic discoveries into groundbreaking treatments
We are accelerating the journey from genetic discovery to groundbreaking therapies in neurology, autoimmune diseases, and inflammatory skin conditions.
A Global Research Network —
Our R&D efforts are augmented by a world-class ecosystem of leading experts, scientists, and research institutions, collaborating to drive genomics-informed breakthroughs in neurology, dermatology, immunology, and inflammation.
The Pulse
-
REYKJAVIK, ICELAND – February 11, 2026 – Arctic Therapeutics (ATx) today announced that the first patients have been enrolled in a Phase IIa randomized, double-blind, placebo-controlled clinical trial evaluating the safety and efficacy of topical AT-004 in patients with acne vulgaris (AV). The study follows regulatory approval from the European Medicines…
